Lv1
60 积分 2023-04-03 加入
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
3小时前
待确认
Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer
7天前
已完结
Cancer incidence and mortality in China, 2022
12天前
已完结
Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir
1个月前
已完结
我国艾滋病抗病毒治疗进展及推进高质量发展的思考
2个月前
已完结
Albumin: a comprehensive review and practical guideline for clinical use
3个月前
已完结
Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir
4个月前
已完结
皖公网安备34019202002308
